167eur
0,5 %
Date:2024-10-09Time:11:05:50Latest report:Q2-2024List:First NorthTicker:NANOFH
Market Cap:142 meurEnterprise Value:97 meurNet Sales:2,30 meurEarnings:-21,7 meurEmployees:0ISIN:FI4000330972

Ratios

10-year key figure history for Nanoform turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanoform with index and moving average MA50 and MA200.

Stockprice:1,67
MA50:1,70
MA200:2,10
Price/MA200:-20,7 %
RSI (14):50,9
Price/MA50:-2,3 %

Description

Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceuticals pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.

Pharmaceuticals